Mehdi Rostami

Mehdi Rostami, Olli Saarela

The estimation of Average Treatment Effect (ATE) as a causal parameter is carried out in two steps, where in the first step, the treatment and outcome are modeled to incorporate the potential confounders, and in the second step, the predictions are inserted into the ATE estimators such as the Augmented Inverse Probability Weighting (AIPW) estimator. Due to the concerns regarding the nonlinear or unknown relationships between confounders and the treatment and outcome, there has been an interest in applying non-parametric methods such as Machine Learning (ML) algorithms instead. Some literature proposes to use two separate Neural Networks (NNs) where there's no regularization on the network's parameters except the Stochastic Gradient Descent (SGD) in the NN's optimization. Our simulations indicate that the AIPW estimator suffers extensively if no regularization is utilized. We propose the normalization of AIPW (referred to as nAIPW) which can be helpful in some scenarios. nAIPW, provably, has the same properties as AIPW, that is, the double-robustness and orthogonality properties. Further, if the first step algorithms converge fast enough, under regulatory conditions, nAIPW will be asymptotically normal. We also compare the performance of AIPW and nAIPW in terms of the bias and variance when small to moderate L1 regularization is imposed on the NNs.

Mehdi Rostami, Olli Saarela, Michael Escobar

The Doubly Robust (DR) estimation of ATE can be carried out in 2 steps, where in the first step, the treatment and outcome are modeled, and in the second step the predictions are inserted into the DR estimator. The model misspecification in the first step has led researchers to utilize Machine Learning algorithms instead of parametric algorithms. However, existence of strong confounders and/or Instrumental Variables (IVs) can lead the complex ML algorithms to provide perfect predictions for the treatment model which can violate the positivity assumption and elevate the variance of DR estimators. Thus the ML algorithms must be controlled to avoid perfect predictions for the treatment model while still learn the relationship between the confounders and the treatment and outcome. We use two Neural network architectures and investigate how their hyperparameters should be tuned in the presence of confounders and IVs to achieve a low bias-variance tradeoff for ATE estimators such as DR estimator. Through simulation results, we will provide recommendations as to how NNs can be employed for ATE estimation.